INTRODUCTION {#SEC1}
============

Genomic DNA in all cells is continuously subjected to extensive chemical modification including damage caused by endogenous and exogenous stresses ([@B1]), intermediates in the repair of this damage ([@B1]), and enzymatically-mediated epigenetic modifications ([@B2]). These mechanisms and processes are well established to have profound influences on genome stability and cell phenotype, with dysregulation causing many human diseases ([@B1],[@B2]). While whole-genome sequencing is now commonplace in the post-genomic era, with the mutational consequences of DNA damage readily mapped across genomes, technologies to accurately and quantitatively localize DNA modifications in genomes are limited and highly specialized. A summary of existing methods for DNA modification mapping is presented in Table [1](#tbl1){ref-type="table"}. For example, single-nucleotide-resolution genomic maps can be obtained for 5-methylcytidine (5mC) and 5-hydromethylcytidine (5hmC) epigenetic marks by a combination of bisulfite derivatization and next generation sequencing (NGS) ([@B3]), while nucleobase methylation and phosphorothioate modifications can be mapped using single-molecule real-time (SMRT) ([@B4]) and nanopore ([@B5]) sequencing technologies. Lower-resolution maps of specific types of DNA damage and modifications can be achieved by enrichment-based sequencing methods such as chromatin immunoprecipitation (ChIP) or chemical labelling coupled with NGS ([@B6],[@B7]), for example. However, all of these techniques are limited to specific modifications, are poorly quantitative, or suffer from low resolution, low sensitivity, and lack of specificity. Here, we describe Nick-seq, a general method for highly sensitive and quantitative genomic mapping at single-nucleotide resolution for any type of DNA modification or damage that can be converted to a strand-break.

###### 

Summary of existing methods for genomic mapping of DNA modifications

  Modifications                       Method                                   Resol'n    Method                  Basis                                                    Limitation                                                 Ref
  ----------------------------------- ---------------------------------------- ---------- ----------------------- -------------------------------------------------------- ---------------------------------------------------------- ----------------
  5mC                                 Bisulfite reaction based                 1 nt       BS-seq                  Differential deamination of C and 5mC to U               Specific to 5mC                                            ([@B22])
  5mC, 5hmC                                                                               oxBS-Seq                5hmC converted to uracil                                 Specific to 5hmC                                           ([@B23])
  6mA, 4mC, 5mC *et al.*              Third generation sequencing              1 nt       SMRT sequencing         Detection during sequencing                              Sensitivity, specificity                                   ([@B4],[@B27])
  5mC; 6mA                                                                                Nanopore sequencing     Detection during sequencing                              Noise, sensitivity, specificity                            ([@B42])
  Methylation status of CpG islands   DNA microarray based                     Low        CpG island microarray   Restriction enzyme digestion; microarray                 Methylation-sensitive restriction enzymes                  ([@B20])
  Methylation                                                                             MeDIP-on-Chip           IP, hybridize of DNA on microarray                       Modification-specific antibody                             ([@B21])
  5mC and 5hmC                        Chemical-labeling for NGS sequencing     1 nt       TAPS                    Oxidation of 5mC/5hmC to 5caC, reduce to dihydrouracil   Specific to 5mC and 5hmC                                   ([@B24])
  8-oxoG                                                                       ∼150 nt    OG-seq                  Derivatize 8-oxoG with biotin                            Specific to 8-oxoG                                         ([@B6])
  AP sites                                                                     1 nt       snAP-seq                Chemical labelling of AP site with biotin                Specific to AP sites                                       ([@B25])
  8-oxoG                                                                       1 nt       Click-code-Seq          BER excision; click chemistry                            DNA 3′-OH end required                                     ([@B31])
  UV-induced DNA lesions              Antibody-enrichment for NGS sequencing   1 nt       XR-seq                  Damaged DNA IP, NGS                                      Lesion-specific antibody                                   ([@B26])
  8-oxoG                                                                       ∼150 nt    OxiDIP-Seq              8-oxoG IP for NGS sequencing                             8-oxoG -specific antibody                                  ([@B12])
  5ghmC, 5hmC                         Modif'n-dependent restriction enzyme     3∼5 nt     Aba-seq                 AbaSI recognizes 5ghmC and 5hmC                          Limited to a narrow spectrum of modifications              ([@B29])
  Uracil, pyrimidine dimer            BER enzyme excision                      \<1 nt     Excision-seq            BER enzyme excision, NGS                                 Very low sensitivty; low-resolution                        ([@B11])
  Single-strand breaks                TdT-labeling                             1 nt       SSiNGLe                 TdT-labeling of strand break, NGS                        T modific'n not detected; limited to SSB only              ([@B36])
  Single-strand breaks                Nick translation                         ?\>1 nt    SSB-seq                 Nick translation with biotin dNTP, IP, NGS               Uncontrolled nuclease S1 trimming; SSB only                ([@B35])
  Double-strand breaks                TdT-labeling                             ?\>10 nt   DSB-seq                 TdT-tailing with labeled dNTP, IP, NGS                   T modific'n not detected; nuclease S1 trimming; SSB only   ([@B35])

MATERIALS AND METHODS {#SEC2}
=====================

Materials {#SEC2-1}
---------

Nicking endonucleases Nb.BsmI, Nb.BspQI, Nb.BsrDI, endonuclease IV, DNA polymerase I, OneTaq DNA polymerase, dNTPs, Nci I, exonuclease III and RecJ~f~ were purchased from New England Biolabs. All DNA oligos were synthesized by Integrated Device Technology, Inc. ddNTPs and α-thio-dNTPs were purchased from TriLink BioTech. Agilent Bioanalyzer 2100 was used for size analysis of DNA fragments. Other chemicals were of molecular biology grade. All cell lines used in this work are readily available from the authors.

Cell growth and preparation of DNA {#SEC2-2}
----------------------------------

The PT-containing strain *Salmonella enterica* serovar Cerro 87 and its genomic DNA were prepared as described previously ([@B8]). *Escherichia coli* DH10B was used for nicking enzyme and H~2~O~2~-induced DNA damage mapping studies. A single colony of *E. coli* DH10B was grown in 5 ml LB medium overnight at 37°C. Cells (1 ml) were harvested by centrifuge at ambient temperature (unless indicated otherwise) and resuspended and diluted with fresh LB medium to a starting optical density at 600 nm (OD~600~) of 0.1, followed by growth at 37°C, 230 rpm until OD~600~ = 0.8 for DNA extraction or H~2~O~2~ treatment. Diluted H~2~O~2~ solution (10 μl) was added to the culture with a final concentration 0.1, 0.5, 1 and 2 mM. As un-exposed control, 10 μl sterile water was used instead of H~2~O~2~. After sitting at ambient temperature for 30 min, 10 μl of the cells were used for lethal dose (LD) analysis by counting the colony formation unit on LB agar plate. The remaining cells were harvested for DNA extraction with an OMEGA bacterial genomic DNA or plasmid isolation kit following the manufacture\'s protocol.

Mapping of modification/damage sites on DNA by NT-dependent method {#SEC2-3}
------------------------------------------------------------------

These studies were initiated by random fragmentation of purified genomic DNA (1 μg) in each of three separate digestions with NciI, or HindIII and XhoI, or SalI, XbaI and NdeI. RNase A was also added to each reaction to remove contaminating RNA. After digestion, the DNA was purified using a Qiagen PCR Purification Kit. The three purified DNA samples were mixed for the blocking step. Blocking of pre-existing strand-break sites was achieved in a reaction mixture (40 μl) containing 4 μl of reaction buffer (NEBcutsmart buffer), 1 μl of shrimp alkaline phosphatase (NEB), and 1 μg of template genomic DNA, with incubation at 37°C for 30 min to remove phosphate at 3′ end of the strand-breaks. The phosphatase was then inactivated by heating at 70°C for 10 min. After cooling, 2 μl of ddNTPs (2.5 mM each, TriLink) and 1 μl of DNA polymerase I (10 U, NEB) was added to the reaction with incubation at 37°C for 40 min to block any pre-existing strand-break sites. Shrimp alkaline phosphatase (1 μl) was then added at 37°C for 30 min to degraded excess ddNTPs and the reaction was terminated by heating at 75°C for 10 min. Following de-salting using a DyeEx column (QIAGEN), the DNA was ready for one of the following nick creation or conversion procedures.

Nicking *E. coli* DH10B genomic DNA with Nb. BsmI and Nb. BsrDI was accomplished in a 50 μl reaction mixture containing 1 μl Nb. BsmI (10 U, NEB), 1 μl Nb. BsrDI (10 U, NEB), 1 μg genomic DNA, and 1× NEBcutsmart buffer incubated at 65°C for 1 h. The reaction was terminated by heating at 80°C for 20 min and cooled down to 4°C at the rate of 0.1°C/s. The reaction product was used for NT or TdT reactions as described below with no further purification.

For mapping PT modifications, 40 μl of blocked DNA from *S. enterica* was mixed with 5 μl of dibasic sodium phosphate buffer (500 mM, pH 9.0) and 2 μl of iodine solution (0.1 N, FLUKA). After incubation at 65°C for 5 min and cooling to 4°C, the reaction product was purified using a DyeEX column (QIAGEN) to remove salts and iodine. The purified product was treated with shrimp alkaline phosphatase by adding 5 μl of NEBcutsmart buffer and 1 μl of phosphatase to remove 3′-phosphates arising from iodine cleavage. After incubation at 37°C for 20 min and 75°C for another 10 min, the product was kept on ice for the following NT or TdT reactions with no additional purification.

For mapping H~2~O~2~-induced AP sites, genomic DNA was extracted from H~2~O~2~-treated *E. coli* and the AP sites converted to strand-breaks in a 50 μl reaction mixture containing 1 μg genomic DNA, endonuclease IV (20 U), and 1X NEBcutsmart buffer, with incubation at 37°C for 60 min. The reaction mixture was then kept on ice and used for the following NT- or TdT- reactions with no further inactivation or purification.

Following splitting of the nicked sample into two portions for NT- and TdT- reactions, the NT- reaction was achieved by further splitting the DNA sample into two parts: one for NT-reaction and the other as a negative control. NT-reaction was performed in a 50 μl reaction system containing 2 μl of α-thio-dNTPs (2.5 mM each, TRILINK), 1× of NEBcutsmart buffer, 2 μl of DNA polymerase I, and the DNA template. The negative control consisted of H~2~O instead of DNA polymerase I. The reaction mixture was incubated at 15°C for 90 min and then terminated by heating at 75°C for 20 min. The product was ready of template DNA digestion after the purification by DyeEx. The template DNA digestion reaction was performed in a 50 μl reaction system containing 200 U of exonuclease III, 5 μl NEBcutsmart buffer and DNA sample by incubating at 37°C for 60 min. The DNA was then denatured by heating at 95°C for 3 min and crashing on ice. RecJ~f~ (60 U) was then added to the reaction mixture with incubation at 37°C for 60 min. For some DNA samples with high complexity of structure and/or modifications, digestion with an additional 60 units of RecJ~f~ might be necessary. After digestion, the enzymes were inactivated by incubation at 80°C for 10 min. The DNA product was then purified using a Zymo Oligo Clean & Concentrator kit (Zymo) following the manufacturer\'s protocol. The purified product was ready for Illumina library preparation.

Illumina library preparation was performed by the Clontech SMART ChIp-seq kit (Clontech) by following the manufacturer\'s protocol. Twelve cycles were used in the final step of PCR amplification. The PCR product of each sample was combined with its corresponding negative control and then size selected using AMPure XP beads (NEB). The purified library was submitted to Illumina NextSeq 500 instrument for 75 bp paired-end sequencing.

Mapping of modification and damage sites by TdT-dependent method {#SEC2-4}
----------------------------------------------------------------

Using the other half of the DNA sample, the steps of DNA fragmentation, blocking and nick conversion are the same as described above in NT-method. Nick-converted DNA (100 ng) was denatured by heating at 95°C for 3 min in 20 μl of H~2~O, followed by adding A poly(T) tail to the ssDNA in a 30 μl reaction system containing 3 μl DNA SMART buffer (Clontech), 1 μl terminal deoxynucleotidyl transferase (TdT, Clontech) and 1 μl DNA SMART T-Tailing Mix (Clontech) by incubating at 37°C for 20 min and terminating the reaction at 70°C for 10 min. The primer annealing and template switching reaction was then performed with the Clontech SMART ChIp-seq kit (Clontech) by following the manufacturer\'s protocol. The final step of PCR was perfomed using the Illumina primers provided in ChIp-seq kit and 12 cycles were used for amplification. The PCR product of each sample, with unique sequencing barcode, was combined with its corresponding negative control and then size selected using AMPure XP beads (NEB). The purified library was submitted to Illumina NextSeq 500 instrument for 75 bp paired-end sequencing.

Data analysis {#SEC2-5}
-------------

Sequencing results were processed on the Galaxy web platform (<https://usegalaxy.org/>). Initially, the paired-end reads were pre-processed by Trim Galore! to remove adapters, as well as trimming the first 3 bp on the 5′ end of read 1. All the reads were aligned to the corresponding genome using Bowtie 2. A custom method for peak calling of sequencing data was developed with BamTools, BEDTools and Rstudio. Briefly, the BamTools results were filtered based on R1 (selected for NT data) or R2 (selected for TdT data). The 5′ coverage (experiment sample and controls) or full coverage (controls) on each position were calculated based on the filtered BamTools results by BEDTools (positive and negative strand separately). For both NT or TdT data on each strand, three '.tabular' files containing the genome position and their corresponding read coverage (sample_coverage_5.tabular, control_coverage_5.tabular, control_coverage_full.tabular) were prepared using R. These data were used to normalize the read coverage by the sequencing depth and then calculate the read coverage ratio of specific position compared to its up- and downstream position in the same sample and the same sample in negative controls. Three ratios were calculated at each position by RStudio for modification site calling: coverage of position N (sample)/coverage of position *N* -- 1(sample), coverage of position *N*(sample)/coverage of position *N* + 1(sample), and coverage of position N(sample)/coverage of position N(control). Positions with a ratio \>1 were retained using the following R scripts: TdT_positive_strand.R TdT_negative_strand.R NT_positive_strand.R NT_negative_strand.R From these datasets, the intersection of the datasets from the NT and TdT methods were calculated using the following R scripts: TdT_positive+NT_negative.R TdT_negative+NT_positive.R The output files (CSV files; Excel format) contain the read coverage ratio information for the putative nick sites. The ratio cutoffs can be varied in the Excel spreadsheet as needed. For example, for site-specific nicking by Nb. BsmI and Nb. BsrDI, we determined that a ratio \>2 was adequate to capture nearly all sites, while for variable sites (PT) or unknown samples (H~2~O~2~), the ratio was increased to 5--10.

RESULTS {#SEC3}
=======

Nick-seq design and data processing workflow {#SEC3-1}
--------------------------------------------

As shown in the Nick-seq method concept and workflow in Figure [1A](#F1){ref-type="fig"}, purified genomic DNA is first subjected to sequencing-compatible fragmentation and the resulting 3′-OH ends are blocked with dideoxyNTPs. The DNA modification is then converted to a strand-break by enzymatic or chemical treatment, followed by capture of the 3′- and 5′-ends of resulting strand-breaks using two complementary strategies. One portion of DNA is subjected to nick translation (NT) with α-thio-dNTPs to generate 100--200 nt phosphorothioate (PT)-containing oligonucleotides that are resistant to subsequent hydrolysis of the bulk of the genomic DNA by exonuclease III and RecJ~f~. The purified PT-protected fragments are used to generate an NGS library with the modification of interest positioned at the 5′-end of the PT-labeled fragment. A second portion of the same DNA sample is used for terminal transferase (TdT)-dependent poly(dT) tailing of the 3′-end of the strand-break, with the tail used to create a sequencing library by reverse transcriptase template switching ([@B9]). Subsequent NGS positions the modification of interest 5′-end of the poly(dT) tail.

![Overview of Nick-seq and data analysis workflow. (**A**) Nick-seq library preparation. Briefly, genomic DNA is first subjected to sequencing-compatible fragmentation; the resulting 3′-OH ends are blocked with dideoxyNTPs; the DNA modification is converted to a strand-break by enzymatic or chemical treatment; capture of the 3′- and 5′-ends of resulting strand-breaks using two complementary strategies: one portion of DNA is subjected to nick translation (NT) with α-thio-dNTPs to generate phosphorothioate (PT)-containing oligonucleotides that are resistant to subsequent hydrolysis of the bulk of the genomic DNA by exonuclease III and RecJ~f~. The purified PT-protected fragments are used to generate an NGS library with the modification of interest positioned at the 5′-end of the PT-labeled fragment. A second portion of the same DNA sample is used for terminal transferase (TdT)-dependent poly(dT) tailing of the 3′-end of the strand-break, with the tail used to create a sequencing library by reverse transcriptase template switching ([@B9]). Subsequent NGS positions the modification of interest 5′-end of the poly(dT) tail. (**B**) Processing of the Nick-seq data includes: raw NGS reads are aligned to the reference genome for read coverage calculation; the genome sites with reads coverage ≥5 are then filtered for nick site calling with three parameters: *x* = the read coverage at position N/coverage at *N* -- 1; *y* = coverage at position N/coverage at *N* + 1; *z* = coverage at position *N*/coverage at *N* of negative control sample. The site *N* is defined as a nick site if its *x* \> 1, *y* \> 1, *z* \> 1 for NT reads and *x* \> 2, *y* \> 2, *z* \> 2 for TdT reads.](gkaa473fig1){#F1}

The workflow for sequencing data processing (Figure [1B](#F1){ref-type="fig"}) uses the NT-derived reads as the primary dataset for developing a preliminary modification map, with TdT-derived reads as complementary corrective data. This hybrid approach exploits the fact that NT is agnostic to the base identify at the damage site but generates a high background of false positive sites, while TdT cannot be used with modifications occurring at dT due to loss of the poly(dT) tail during data analysis. The TdT reads are used to correct NT false-positive reads. For example, if NT maps a strand-break at T 1000 in the genome, then TdT reads are examined for a strand-break at position 999 and 1001. This one-nucleotide shift accommodates poly(dT) tail removal during data processing and validates the NT map. If TdT does not call a strand-break at 999 or 1001, then the NT result is considered a false positive. In other cases, if the NT-detected site occurs at a G, C or A, then TdT validates the same site. The use of both methods increases the sensitivity and specificity of the resulting genomic map.

Method validation by quantitative mapping of genomic DNA strand breaks {#SEC3-2}
----------------------------------------------------------------------

We validated Nick-seq by mapping DNA single-strand-breaks caused by the site-specific endonuclease Nb.BsmI, which cuts at G/CATTC motifs of which there are 2681 in the *E. coli* genome. Purified *E. coli* DNA was treated with Nb.BsmI and the Nick-seq-processed library sequenced using the Illumina NextSeq platform with an average of 10^7^ raw sequencing reads for each sample (Figure [2A](#F2){ref-type="fig"}). Paired-end sequencing confirmed that \>80% of reads uniquely aligned to the *E. coli* genome ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). For subsequent reads enrichment (Figure [1B](#F1){ref-type="fig"}), we calculated position-wise coverage values using the 5′-end of sequencing reads (NT read 1, TdT read 2) and used these values to define Nick-seq peaks as having \>5 reads and 2-times more reads than sites located one-nucleotide up- and downstream. We then calculated the coverage ratio of the peaks relative to corresponding sites in an untreated DNA control. To identify the optimal minimal coverage ratio, we varied the ratio and calculated the number of identified sites at each ratio value (Figure [2B](#F2){ref-type="fig"}). As the coverage ratio increased from 2 to 7 for the combined TdT and NT data, the number of identified sites decreased from 92% to 59% of the 2681 expected sites ('sensitivity'), while the accuracy (the number of identified sites divided by the number of expected sites; 'specificity') only increased from 98% to 99.5%. To maximize sensitivity, we chose a coverage ratio of 2, which allowed identification of 2462 (97.5%) of the predicted Nb.BsmI sites (Figure [2C](#F2){ref-type="fig"}, [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Another 1% of called sites ([@B10]) occurred in sequences differing from the consensus by one nucleotide. These sites showed lower average sequencing coverage (75 versus 1318) and likely represent Nb.BsmI 'star' activity. A second validation experiment with Nb.BsrDI, which cuts at N/CATTGC, showed no evident 3′-end sequence bias for DNA break site detection ([Supplementary Table S3, Figure S1](#sup1){ref-type="supplementary-material"}). These control studies showed that Nick-seq has high accuracy and sensitivity for single-nucleotide genomic mapping of DNA strand-breaks.

![Nick-seq validation. (**A**) Mapping single-strand breaks produced by Nb.BsmI in *E. coli* genomic DNA. *Middle panel*: Representative view of sequencing reads distributed in one genomic region. Red and green peaks mark reads mapped to forward and reverse strands of the genome, respectively. *Lower panel*: Amplification of the genomic region surrounding one peak, with read pile ups for TdT and NT sequencing converging on the site of the strand-break. (**B**) Nb.BsmI mapping data were used to define data processing parameters for accuracy and sensitivity of Nick-seq. Coverage ratios (the ratio of the peaks relative to corresponding sites in an untreated DNA control) were calculated for sequencing data performed with TdT alone (blue line) or the combination of TdT and NT (orange line). The sensitivity and specificity for detection of site-specific strand-breaks was then plotted for ratios ranging from 2 to 7. In general, higher coverage ratios yield greater accuracy but lower sensitivity, and the combination of TdT and NT provided significantly greater specificity. (**C**) With a coverage ratio of 2, Nick-seq identified 2462 (97.5%) of the 2681 predicted Nb.BsmI sites. Among the 62 (2.5%) 'false-positive' sites, 27 (1%) of them occurred in sequences differing from the consensus by one nucleotide. These sites showed lower average sequencing coverage (75 versus 1318) and likely represent Nb.BsmI 'star' activity.](gkaa473fig2){#F2}

Genomic mapping of DNA phosphorothioate modification by Nick-seq {#SEC3-3}
----------------------------------------------------------------

The validated Nick-seq was applied to map the naturally-occurring phosphorothioate (PT) DNA modifications in *Salmonella enterica* serovar Cerro 87, using iodine to oxidize PTs to produce DNA strand-breaks ([@B8]) (Figure [3A](#F3){ref-type="fig"}). Using SMRT sequencing, we previously established that PTs occur as bistranded modifications at 10--15% of the 40,701 GAAC/GTTC motifs in the genome of *E. coli* B7A, which shares a nearly identical Dnd modification system as *S. enterica* Cerro 87 ([@B8]). Nick-seq recognized 12 239 PT sites in *S. enterica*, of which 11 684 (96%) occurred among the 32 795 possible G~PS~AAC/G~PS~TTC sites (37%), with 8568 (73%) modified on both strands and 27% modified on one strand (Figure [3B](#F3){ref-type="fig"}; data for PT sites on the *S. enterica* genome are detailed in [Supplementary Table S4](#sup1){ref-type="supplementary-material"}). This agrees with our previous observations using the orthogonal SMRT sequencing method ([@B8]). In addition to GAAC/GTTC motifs, Nick-seq also revealed less abundant PTs at G~PS~TAC (168), G~PS~ATC ([@B11]), and G~PS~AAAC or G~PS~AAAAC sites ([@B12]), with half of G~PS~TAC and G~PS~ATC sites modified on only one strand. These results indicate that Nick-seq has a higher sensitivity to detect PT modifications than SMRT sequencing ([@B8]).

![Mapping PTs across the *S. enterica* genome by Nick-seq. (**A**) Schematic showing the iodine cleavage method for converting PTs to strand-breaks. (**B**) the number of PT modification sites identified by Nick-seq in different sequence motifs. A total of 11 684 breaks were detected at the expected GAAC/GTTC motif, with single- and double-strand PTs denoted by a red 'S'. The blow up shows minor modification motifs.](gkaa473fig3){#F3}

Nick-seq reveals H~2~O~2~-induced oxidative DNA damage sites on genome {#SEC3-4}
----------------------------------------------------------------------

Finally, we applied Nick-seq to DNA modifications not previously subjected to genomic mapping: oxidatively-induced abasic sites. Apurinic and apyrimidinic (AP) sites represent a prevalent and toxic form of DNA damage that blocks DNA replication and transcription ([@B13]). AP sites arise as intermediates in base excision DNA repair, in which damaged bases are excised by DNA glycosylases and the resulting AP sites are cleaved by AP endonucleases ([@B14]). AP sites can also arise by oxidation of DNA on both the nucleobase and 2′-deoxyribose moieties ([@B15]), as well as by demethylation of m^5^C epigenetic marks ([@B16]). In spite of the importance of AP sites, little is known about their formation, persistence, and distribution in genomic DNA. Here, we used Nick-seq to profile AP sites in *E. coli* exposed to hydrogen peroxide (H~2~O~2~) at a non-lethal dose of 0.2 mM (the LD~50~ for *E. coli is* ∼5 mM) (Figure [4A](#F4){ref-type="fig"}). Following DNA purification, AP sites were expressed as strand-breaks using endonuclease IV (EndoIV), which cleaves both native and oxidized AP sites ([@B15],[@B17]). Nick-seq identified 1,519 EndoIV-sensitive sites in the genome (Figure [4B](#F4){ref-type="fig"}), as well as 82 sites in an endogenous plasmid (Figure [4C](#F4){ref-type="fig"}), with an unexposed sample of cells showing 11 and 8 sites, respectively. Data for AP sites in the *E. coli* genome and plasmid are detailed in [Supplementary Tables S5 and S6](#sup1){ref-type="supplementary-material"}. Considering the nucleobase precursor of the AP site, there was a weak preference for thymine (33%) followed by adenine (25%), cytosine (24%), and guanine (18%), with a similar distribution in the plasmid. This suggests that H~2~O~2~-derived DNA oxidizing agents either do not selectively oxidize guanine as predicted ([@B18]) or that the predominant form of damage is DNA sugar oxidation. However, there was a more pronounced sequence context effect. Analysis of the sequences 15 bp up- and down-stream of the AP sites revealed a strong preference for cytosine (47%) at --1 relative to the AP sites ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). The distribution of AP sites was also non-random (Figure [4D](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}). We observed the AP sites on the plasmid clustering in three regions related to DNA replication and transcription: the F1 origin, pUC origin, and Amp^R^ gene (Figure [4E](#F4){ref-type="fig"}, Table [2](#tbl2){ref-type="table"}). AP site clustering near DNA replication sites was observed previously by immunostaining ([@B19]), suggesting that the transcriptionally active and single-strand DNA are vulnerable to oxidatively-induced AP sites. We tested this by analyzing the distribution of AP sites in the *E. coli* genome relative to origins of replication (OriC), coding sequences, and non-coding sequences ([Supplementary Table S5](#sup1){ref-type="supplementary-material"}). While there was an average of 0.32 AP sites/kbp (1519 AP per 4 686 000 bp), the 20 kbp region around OriC showed 0.70 AP sites/kbp. Nick-seq also revealed 1401 AP sites in the 4.1 × 10^6^ bp coding sequence region (0.34 AP/kb), and 118 AP sites (0.20 AP/kb) in the 0.58 × 10^6^ bp non-coding region. These results suggest a preference for AP sites in DNA undergoing replication or transcription during H~2~O~2~ stress.

![Application of Nick-seq to quantify abasic sites. (**A**) generated by H~2~O~2~ exposure in *E. coli*. Cells were treated with a non-lethal dose of H~2~O~2~ (0.2 mM) and AP sites in isolated DNA were converted to strand-breaks with EndoIV, followed by Nick-seq mapping. (**B**) Detection of H~2~O~2~-induced EndoIV- sensitive DNA damage sites in *E. coli*. genomic DNA by Nick-seq. Data for AP sites in the *E. coli* genome are detailed in [Supplementary Table S5](#sup1){ref-type="supplementary-material"}. (**C**) Detection of H~2~O~2~-induced EndoIV- sensitive DNA damage sites in a plasmid maintained in this strain of *E. coli*. Data for AP sites in the *E. coli* genome are detailed in [Supplementary Table S6](#sup1){ref-type="supplementary-material"}. (**D**) The circos plot shows the locations of EndoIV-sensitive sites in *E.coli* genomic DNA. Outward from the center, circles represent: 0 and 0.2 mM H~2~O~2~ induced EndoIV-specific DNA damage sites. (**E**) The distribution of EndoIV-sensitive sites in the plasmid. Outward from the center, circles represent: 0 and 0.2 mM H~2~O~2~ induced EndoIV-specific DNA damage sites.](gkaa473fig4){#F4}

###### 

Frequency of AP sites distributed on an endogenous plasmid in H~2~O~2~-treated *E. coli*

  H~2~O~2~     Functional region   Start position   End position   Size (bp)   \# AP sites   Frequency   Sum of frequency
  ------------ ------------------- ---------------- -------------- ----------- ------------- ----------- ------------------
  **0 mM**     F1(+) Origin        135              441            306         1             0.33%       0.35%
               LacZ(α)             460              816            356         1             0.28%       
               LacZ Promoter       817              938            121         0             0%          
               pUC Origin          1158             1825           667         3             0.45%       
               Amp^R^ Gene         1976             2833           857         3             0.35%       
               Others                                              654         0             0%          0%
               Average                                             2961        8             0.27%       0.27%
  **0.2 mM**   F1(+) Origin        135              441            306         22            7.2%        3.2%
               LacZ(α)             460              816            356         11            3.1%        
               LacZ Promoter       817              938            121         2             1.6%        
               pUC Origin          1158             1825           667         14            2.1%        
               Amp^R^ Gene         1976             2833           857         25            2.9%        
               Others                                              654         8             1.2%        1.2%
               Average                                             2961        82            2.8%        2.8%

DISCUSSION {#SEC4}
==========

The ability to map DNA damage and physiological modifications at single nucleotide-resolution across genomes is critical to understanding the biological function of epigenetic marks and the mutational and genomic instability consequences of DNA lesions caused by both endogenous and exogenous genotoxic agents. As summarized in Table [1](#tbl1){ref-type="table"}, the wide recognition of the impact of genome mapping is evident in the growing number of methods that couple DNA sequencing technology with chemical derivatisation of the DNA modifications, enrichment of modified DNA fragments, or deconvolution sequencing signals to identify the modifications. Resolution at the level of hundreds of nucleotides can be achieved by fragmenting the DNA followed by affinity purification of modification-containing fragments using antibodies or other affinity reagents ([@B6],[@B12],[@B20],[@B21]). To locate a modified base at single-nucleotide resolution, a selective chemical transformation of the modified nucleotides must be applied, with subsequent DNA processing that preserves the location of the modification at the exact 5′- or 3′-end of the final DNA fragment in the sequencing library ([@B22]). For example, bisulfite selectively deaminates C, but not 5mC, to T, with routine DNA sequencing revealing the C as a T mutation and 5mC retained as C, which can be confirmed by parallel sequencing of untreated DNA ([@B22]). Similarly, 5hmC can be oxidized to 5-formylcytidine (5fC) that is then converted to U by bisulfite, with deconvolution by comparison of the C-to-U transition in the genomic maps ([@B23]). Single-nucleotide resolution can also be achieved with third-generation sequencing technologies such as SMRT and nanopore sequencing, although both approaches suffer from low sensitivity due to the need to distinguish modification-specific signals from noise, with many modifications not producing a detectable signal ([@B4],[@B27]).

Considering the fact that many types of DNA modifications can be converted to strand-breaks with modification-dependent restriction endonucleases (MRE) ([@B28]), DNA base excision repair (BER) enzymes ([@B10]) and their associated AP endonucleases ([@B14]), and nucleotide excision repair ([@B10]) enzymes, several groups have attempted to detect DNA lesion-derived strand breaks instead of the lesion itself. For example, the MRE AbaSI cleaves DNA on either side of 5-glucosylhydroxymethylcytosine (5ghmC) and 5hmC to facilitate mapping ([@B29]). However, the limited availability and specificity of MREs makes them highly specialized tools for modification mapping.

Both BER and NER enzymes excise DNA damage products with predictable precision necessary for single-nucleotide resolution mapping. For example, the Burrows group succeeded in detecting DNA lesions on synthesized oligonucleotides by installation of either the dNaM or d5SICS (marker nucleotide) at the lesion site after processing with a BER enzyme followed by Nanopore sequencing to detect the dNaM or d5SICS ([@B30]). Another method developed by Hesselberth and coworkers, Excision-seq, applies BER enzymes coupled with NGS to map several types of DNA damage on a genomic scale ([@B11]). Excision-seq comprises two approaches: a 'pre-digestion' method relying on closely-spaced BER enzyme-sensitive damage to create 5′ and 3′ ends for double-strand ligation. This requires very high, biologically-irrelevant levels of the damage product. The 'post-digestion' method in Excision-seq uses pre-sheared, BER-treated genomic DNA to destroy the damage-containing DNA fragments, which allows identification of undamaged regions of the genome. Thus, this method suffers from low resolution and low sensitivity, with a PCR step that could confound the sequencing if PCR-blocking modifications are present. The Sturla group mapped 8-oxoG in the yeast genomic DNA using a method they termed Click-code-Seq. Here, the free 3′-OH generated by BER enzyme excision was labelled with a synthetic *O*-3′-propargyl-modified 2′-deoxyribonucleotide (prop-dGTP) to generate a 3′-alkynyl-modified DNA that can be ligated and enriched by a 5′-azido- and biotin-modified code sequence using a copper(I)-catalyzed click reaction and biotin-avidin affinity purification ([@B31]). Both Excision-seq and Click-code-seq methods could be adapted to analyze other types of DNA damage with appropriate BER and NER enzymes. The main limitation of using DNA repair enzymes to express damage as strand-breaks, including Nick-seq, lies in the relatively broad specificity of the enzymes for different chemical classes of damage (Table [3](#tbl3){ref-type="table"}) ([@B32]), as well as dual enzymatic functions. For example, *E. coli* FAPY DNA glycosylase (Fpg) recognizes a variety of oxidized purine base products, and contains an AP endonuclease activity ([@B33],[@B34]). Similarly, *E. coli* NTH recognizes oxidized pyrimidine nucleobase lesions ([@B34]). However, the catalytic efficiency and specificity of DNA repair enzymes is high enough to confidently map relatively narrow classes of damage products using different sets of enzymes.

###### 

DNA modifications and damage amenable to Nick-seq mapping

  DNA modification                                                                  Base excision enzyme**^a^**     Additional processing**^b^**   Reference
  --------------------------------------------------------------------------------- ------------------------------- ------------------------------ -----------
  DNA repair intermediates (abasic sites, strand-breaks)                            None                            Endo IV (NEB)                  ([@B15])
  Bulky adducts formed by benzo\[a\]pyrene, acrolein, aflatoxin, et al.             UvrABC                          None                           ([@B43])
  8-Oxoguanine, formamidopyrimidine                                                 FPG, hOGG1 (NEB)                None                           ([@B44])
  UV photodimers (TT, TC, CC)                                                       T4 Endo V (NEB)                 Endo IV (NEB) for 3′-UA        ([@B45])
  1,N^6^-Ethenoadenine, hypoxanthine                                                hAAG (NEB)                      Endo IV (NEB) for AP           ([@B45])
  Uracil                                                                            UDG (NEB)                       Endo IV (NEB) for AP           ([@B45])
  A:8-oxoG mispair                                                                  MutY (RD)                       None                           ([@B45])
  Thymine glycol, 5-hydroxyuracil, 6-dihydroxythymine, 5-hydroxycytosine, urea      Endo III (NEB)                  Endo IV (NEB) for AP           ([@B46])
  T:G mispair                                                                       TDG (RD)                        Endo IV (NEB) for AP           ([@B45])
  N^3^-Methylcytosine, N^1^-methyladenine, N^3^-methyladenine, N^7^‐methylguanine   AlkC, AlkD                      Endo IV (NEB) for AP           ([@B47])
  Hypoxanthine, xanthine                                                            *E. coli* EndoV (NEB)           Endo IV (NEB) for AP           ([@B48])
  Single-strand nicking endonucleases                                               \>20 types (NEB)                None                           ([@B49])
  5-Methylcytosine                                                                  TET, TDG                        Endo IV (NEB) for AP           ([@B50])
  5-Methylcytosine                                                                  DEMETER, ROS1, DML2 and DML3    Endo IV (NEB) for AP           ([@B51])
  5-Methylcytosine                                                                  Bisulfite seq + TDG (RD)        Endo IV (NEB) for AP           ([@B52])
  5-Hydroxymethyl-cytosine                                                          TET/bisulfite seq. + TDG (RD)   Endo IV (NEB) for AP           ([@B52])
  DNase I footprinting                                                              DNase I (NEB)                   None                           ([@B53])

^a^Enzyme suppliers in parentheses: NEB, New England Biolabs; RD, R&D Systems; other abbreviations: TDG, thymine DNA glycosylase; Endo, endonuclease; UDG, uracil DNA glycosylase.

^b^Processing to remove 3′-α, β-unsaturated aldehydes (3′-UA) or abasic (AP) sites for Nick-seq library preparation ([@B46]).

Two groups have reported methods similar to Nick-seq for genome-wide mapping of single-strand breaks (Table [1](#tbl1){ref-type="table"}). Baranello *et al.* ([@B35]) used both TdT-tailing and NT to label 3′-hydroxyl-ended double- (DSB-seq) and single-strand breaks (SSB-seq), respectively, with biotinylated and digoxigenin-labeled nucleotides, respectively, for affinity enrichment of the labelled DNA fragments. In addition to a lack of quantitative validation, the DSB-seq method cannot be used to map single-strand breaks occurring at Ts due to the polyA-tailing problem noted earlier. Furthermore, for both DSB-seq and SSB-seq, an imprecise exonuclease trimming step to remove the biotin and digoxigenin tags confounds subsequent localization of the break site ([@B35]). These methods are thus potentially useful for genomically ballparking strand-breaks but not for quantitative single-nucleotide resolution.

The other method, SSiNGLe, is quite different from Nick-seq and is limited solely to mapping single-strand breaks with 3′-hydroxyl groups ([@B36]). Unfortunately, the method cannot be applied to any other form of DNA modification or damage and cannot be used for single-strand breaks with 'dirty 3′-ends' as occur in DNA repair intermediates (e.g. 3′-\[4-hydroxy-5-phospho-2-pentenal\] or 3′-phosphate) and strand-breaks caused by DNA oxidation (e.g. 3′-formylphosphate and others) ([@B37]). The requirement for micrococcal nuclease fragmentation of the DNA in formaldehyde-fixed nuclei prior to DNA purification further restricts the method since chemical or enzymatic conversion of DNA modifications to single-strand breaks will be biased by the presence of chromatin proteins, as occurs in chromatin footprinting methods that use chemicals or ionizing radiation (e.g. see ([@B38]). In fact, the DNA fragmentation with micrococcal nuclease relies on the presence of nucleosomes to limit the fragmentation to the ∼150 nt periodicity of nucleosome-bound DNA ([@B40]). Furthermore, the accuracy of SSiNGLe for single-nucleotide resolution is relatively low, with only 87--95% of the breaks mapping to ± 1 nt of the true cutting site of the single-strand endonuclease Nt.BbvCI used to validate the method ([@B36]), with no mention of the number of missed consensus sites. The combination of NT and TdT labelling in Nick-seq significantly increases the accuracy of the method, with 98% of the exact cutting sites accurately called. Finally, SSiNGLe cannot be used to map single-strand breaks occurring at Ts due to the polyA-tailing problem noted earlier.

Compared to existing methods (Table [1](#tbl1){ref-type="table"}), Nick-seq provides a highly sensitive and quantitative general approach to mapping a variety of epigenetic marks and DNA damage products (Table [3](#tbl3){ref-type="table"}) at single-nucleotide resolution in any genome. While the two complementary sequencing strategies---NT and TdT tailing---can be used individually for genomic mapping of DNA strand breaks, the pairing of the two approaches increases the sensitivity and accuracy of the mapping. Each library preparation approach complements the deficiencies of the other: NT generates a nuclease-resistant PT-labeled oligonucleotide that obviates the TdT problem of assigning break sites at thymines, while the TdT library preparation produces lower background sequencing signals than NT. We believe that the relatively high background associated with NT mapping resulted from the use of exonuclease III (3′→5′ direction) combined with RecJf (5′→3′) for hydrolysis of genomic DNA and release of the phosphorothioate-containing oligonucleotides generated by NT with α-thio-dNTPs. Nuclease P1 is another nuclease that is inhibited by naturally-occurring *R~p~* configuration PT linkages and we have successfully used it for DNA hydrolysis to release PT-containing dinucleotides in our chromatography-coupled mass spectrometry method for quantifying PTs ([@B8]). Indeed, we initially used nuclease P1 in the development of the NT method and it showed higher efficiency for removal of genomic DNA and lower background sequencing noise than the ExoIII/RecJf combination. However, batch to batch contamination of commercial preparations of nuclease P1 with PT-cleaving nucleases obviated the use of this nuclease in Nick-seq.

Nick-seq was shown to be highly sensitive and accurate for mapping DNA breaks and modifications at single-nucleotide resolution. The method detected 2462 of the 2681 Nb.BsmI sites in the *E. coli* genome, which amounts to \>97% specificity and \<1% false positives. In the mapping of PT modifications in the *S. enterica* genome, Nick-seq revealed 2- to 3-times the density of modification sites, with ∼30% of GAAC/GTTC motifs modified, compared to our previous studies of SMRT PT mapping in *E. coli* B7A (10--15% modified), which possesses an identical Dnd protein system that targets GAAC/GTTC ([@B8]). This is not surprising since SMRT sequencing technology is relatively insensitive to PT modifications compared to DNA methylation and relies on sampling statistics to call a particular modification site ([@B8]). Interestingly, among the extra detected sites in *S. enterica*, PTs were found in GATC sites well-known for Dam-mediated methylation (G^6m^ATC). This agrees with our previous observation that d(G~PS~^6m^A) dinucleotides was detected at low levels in mass spectrometric analyses of this *E.coli* strain. Finally, while our observation of AP sites enriched in sites of replication and transcription is consistent with other published studies ([@B19]), the use of Nick-seq to map H~2~O~2~-induced AP sites revealed an unexpected formation of AP sites at roughly equal proportions at T, C, A and G, which is not consistent with the idea -- based on studies in purified DNA -- that G should be the most reactive site for oxidation ([@B18]). This is not altogether surprising since AP sites can arise by both 2′-deoxyribose and nucleobase oxidation in DNA, with our results revealing new features AP site formation *in vivo*. It will be especially informative to compare the AP site maps to maps of DNA glycosylase-sensitive lesions at both purines and pyrimidines (Table [3](#tbl3){ref-type="table"}).

As detailed in Table [3](#tbl3){ref-type="table"}, there are numerous potential applications of Nick-seq for genomic mapping of DNA modifications, including a variety of DNA damage products, DNA repair intermediates (abasic sites, strand-breaks), and epigenetic marks (e.g. 5-methylcytosine, 5-hydroxymethylcytosine). The method can also be used to characterize restriction break sites in many restriction-modification systems ([@B41]) and mapping genomic landmarks by DNase I footprinting ([@B40]), for example. Nick-seq thus provides a widely-applicable, efficient, label-free approach to quantitative mapping of DNA damage and modifications in genomes.

DATA AVAILABILITY {#SEC5}
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Custom scripts for processing the sequencing data are described in Methods and are available at <https://github.com/BoCao2019/Nick-seq:> .gitignore, NT_negative_strand.R, NT_positive_strand.R, TdT_negative+NT_positive.R, TdT_negative_strand.R, TdT_positive+NT_negative.R, and TdT_positive_strand.R.

Sequencing data has been deposited in NCBI GEO database under accession numbers GSE138070, GSE138173 and GSE138476.
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